| SPECIES: | Human |
| SOURCE SPECIES: | Human Cells |
| SEQUENCE: | Met1-Pro261 |
| FUSION TAG: | C-6 His tag |
| TESTED APPLICATIONS: | |
| APPLICATIONS: | This recombinant protein can be used for biological assays. For research use only. |
Specifications| PURITY: | Greater than 95% as determined by reducing SDS-PAGE. Endotoxin level less than 0.1 ng/ug (1 IEU/ug) as determined by LAL test. |
| PREDICTED MOLECULAR WEIGHT: | 28 kD |
| PHYSICAL STATE: | Liquid |
| BUFFER: | Supplied as a 0.2 um filtered solution of 20mM Trsi HCL pH-8,0.1M NaCl,1mM DTT & 10% glycerol. It is not recommended to reconstitute to a concentration less than 100 ug/ml. |
| STORAGE CONDITIONS: | Store at -20˚C, stable for 6 months after receipt. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| ALTERNATE NAMES: | 3-hydroxyacyl-CoA dehydrogenase type-2, 17-beta-hydroxysteroid dehydrogenase 10, 17-beta-HSD 10, 3-hydroxy-2-methylbutyryl-CoA dehydrogenase, 3-hydroxyacyl-CoA dehydrogenase type II, HSD17B10 |
| ACCESSION NO.: | Q99714 |
| OFFICIAL SYMBOL: | HSD17B10 |
| GENE ID: | 3028 |
| BACKGROUND: | 3-hydroxyacyl-CoA dehydrogenase type-2(HSD17B10) belongs to the short-chain dehydrogenases/reductases (SDR) family. HSD17B10 is ubiquitously expressed in normal tissues but is overexpressed in neurons affected in AD. It functions in mitochondrial tRNA maturation. It catalyzes the beta-oxidation at position 17 of androgens and estrogens and has 3-alpha-hydroxysteroid dehydrogenase activity with androsterone. It also catalyzes the third step in the beta-oxidation of fatty acids and carries out oxidative conversions of 7-alpha-OH and 7-beta-OH bile acids. The protein exhibits 20-beta-OH and 21-OH dehydrogenase activities with C21 steroids. By interacting with intracellular amyloid-beta, HSD17B10 may contribute to the neuronal dysfunction associated with Alzheimer disease (AD). |
FOR RESEARCH USE ONLY.
For additional information, visit ProSci's Terms & Conditions Page.
